Zobrazeno 1 - 10
of 1 133
pro vyhledávání: '"Brudi, P."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wael Al Mahmeed, Sherif Bakir, Salem A Beshyah, Bassem Morcos, Sameh Wajih, Martin Horack, Dominik Lautsch, Baishali Ambegaonkar, Philippe Brudi, Carl A Baxter, Ami Vyas, Anselm K Gitt
Publikováno v:
Heart Views, Vol 20, Iss 2, Pp 37-46 (2019)
Background: Careful management of lipid abnormalities in patients with coronary heart disease (CHD) or an acute coronary syndrome (ACS) can reduce the risk of recurrent cardiovascular events. The extent of hyperlipidemia in these very high-risk patie
Externí odkaz:
https://doaj.org/article/6f70125cea474dc4b4b2bf07d1a93688
Autor:
Mohamed Sobhy, Adel El Etriby, Amany El Nashar, Sameh Wajih, Martin Horack, Philippe Brudi, Dominik Lautsch, Baishali Ambegaonkar, Ami Vyas, Anselm K. Gitt
Publikováno v:
The Egyptian Heart Journal, Vol 70, Iss 3, Pp 129-134 (2018)
Background: Effective management of hyperlipidemia is of utmost importance for prevention of recurring cardiovascular events after an acute coronary syndrome (ACS). Indeed, guidelines recommend a low-density lipoprotein cholesterol (LDL-C) level of
Externí odkaz:
https://doaj.org/article/375d8b5c13d34fb781949ab4416a4ed6
Autor:
Anselm K. Gitt, Dominik Lautsch, Jean Ferrières, Gaetano M. De Ferrari, Ami Vyas, Carl A. Baxter, Lori D. Bash, Veronica Ashton, Martin Horack, Wael Almahmeed, Fu-Tien Chiang, Kian Keong Poh, Philippe Brudi, Baishali Ambegaonkar
Publikováno v:
Data in Brief, Vol 18, Iss , Pp 1937-1940 (2018)
DYSIS II CHD was a longitudinal, observational study in 6794 patients from 18 countries. They were attending an outpatient physician appointment for coronary heart disease (CHD). 6370 patients (93.8%) were on active lipid lowering therapy (LLT). The
Externí odkaz:
https://doaj.org/article/72b6ea01da3448e59793e75a6c86d0f7
Autor:
Evangelos Liberopoulos, Loukianos Rallidis, Filio Spanoudi, Elena Xixi, Anselm Gitt, Martin Horack, Veronica Ashton, Philippe Brudi, Dominik Lautsch, Baishali Ambegaonkar, Moses Elisaf
Publikováno v:
Archives of Medical Science, Vol 15, Iss 4, Pp 821-831 (2018)
Externí odkaz:
https://doaj.org/article/7e3fd18c93cf4cc18f3e8e264ae9ff9d
Autor:
Anselm K. Gitt, Dominik Lautsch, Jean Ferrières, Gaetano M. De Ferrari, Ami Vyas, Carl A. Baxter, Lori D. Bash, Veronica Ashton, Martin Horack, Wael Almahmeed, Fu-Tien Chiang, Kian Keong Poh, Philippe Brudi, Baishali Ambegaonkar
Publikováno v:
Data in Brief, Vol 16, Iss , Pp 369-375 (2018)
DYSIS II ACS was a longitudinal, observational study in 3867 patients from 18 countries. They were being hospitalized after suffering an acute coronary syndrome. Evaluations were performed at the time of admission and again 120±15 days following the
Externí odkaz:
https://doaj.org/article/41f5b3bf196d46d2b084b17854037a2d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anselm K. Gitt, Dominik Lautsch, Jean Ferrieres, John Kastelein, Heinz Drexel, Martin Horack, Philippe Brudi, Brecht Vanneste, Peter Bramlage, Francois Chazelle, Vasilisa Sazonov, Baishali Ambegaonkar
Publikováno v:
Data in Brief, Vol 9, Iss C, Pp 616-620 (2016)
Data presented here refer to 57,885 patients on lipid-lowering statin therapy from the Dyslipidaemia International Study (DYSIS) registry. Subjects were divided into 3 discrete subsets: those at very high-risk, high-risk, and non-high-risk for cardio
Externí odkaz:
https://doaj.org/article/15c7ec6df7d444fda1e1b84ab7f4acb9
Autor:
Bryan Brautigam, Chelsea Herholdt, William Farnsworth, Ellen Brudi, Eric McDonald, Guang Wu, Stephen Contakes
Publikováno v:
Acta Crystallographica Section E: Crystallographic Communications, Vol 71, Iss 9, Pp 1100-1104 (2015)
The title compound, [CoFe(C5H5)(C16H14N2O2)(C11H9N2O)], was prepared as an air-stable red–brown solid by mixing equimolar amounts of {2,2′-[ethane-1,2-diylbis(nitrilomethanylylidene)]diphenolato}cobalt(II) and N-ferrocenylisonicotinamide in dry d
Externí odkaz:
https://doaj.org/article/979a3f2758154c9b8639d13deebd95f7